Although sickle cell anemia was the first molecular disease
to be identified, its complex and fascinating pathophysiology is still not
fully understood. A single mutation in the beta-globin gene incurs numerous
molecular and cellular mechanisms that contribute to the plethora of symptoms
associated with the disease. Our knowledge regarding sickle cell disease
mechanisms, while still not complete, has broadened considerably over the last
decades. Sickle Cell Anemia: From Basic
Science to Clinical Practice aims to provide an update on our current
understanding of the disease’s pathophysiology and use this information as a
basis to discuss its manifestations in childhood and adulthood. Current
therapies and prospects for the development of new approaches for the
management of the disease are also covered.
Although sickle cell anemia was the first molecular disease to be identified, its complex and fascinating pathophysiology is still not fully understood. A single mutation in the beta-globin gene incurs numerous molecular and cellular mechanisms that contribute to the plethora of symptoms associated with the disease. Our knowledge regarding sickle cell disease mechanisms, while still not complete, has broadened considerably over the last decades. Sickle Cell Anemia: From Basic Science to Clinical Practice aims to provide an update on our current understanding of the disease’s pathophysiology and use this information as a basis to discuss its manifestations in childhood and adulthood. Current therapies and prospects for the development of new approaches for the management of the disease are also covered. An update on the medical literature regarding sickle cell disease Provides scientific basis to explain the clinical aspects of sickle cell disease Co-authored by international clinicians and scientists with years of experience in studying and managing the disease